S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: NovaBay Pharmaceuticals [NBY]

交易所: AMEX 工业: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

最后更新时间4 May 2024 @ 04:00

5.44% $ 0.0949

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands...

Stats
今日成交量 1.46M
平均成交量 2.31M
市值 3.42M
EPS $0 ( 2024-04-04 )
下一个收益日期 ( $-0.150 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0200
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-06-09 Freiman Paul E. Buy 858 Restricted Stock Units
2023-06-09 Garlikov Julie Buy 858 Restricted Stock Units
2023-06-09 Zheng Yenyou Buy 858 Restricted Stock Units
2023-06-09 Zheng Yongxiang Buy 858 Restricted Stock Units
2023-06-09 Sit Swan Buy 858 Restricted Stock Units
INSIDER POWER
-54.67
Last 96 transactions
Buy: 2 335 940 | Sell: 2 184 002

音量 相关性

長: 0.00 (neutral)
短: 0.19 (neutral)
Signal:(52.002) Neutral

NovaBay Pharmaceuticals 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

NovaBay Pharmaceuticals 相关性 - 货币/商品

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

NovaBay Pharmaceuticals 财务报表

Annual 2023
营收: $14.73M
毛利润: $7.90M (53.61 %)
EPS: $-2.29
FY 2023
营收: $14.73M
毛利润: $7.90M (53.61 %)
EPS: $-2.29
FY 2022
营收: $14.40M
毛利润: $7.78M (54.02 %)
EPS: $-10.10
FY 2021
营收: $8.42M
毛利润: $5.65M (67.03 %)
EPS: $-9.42

Financial Reports:

No articles found.

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。